Yoshikazu Otsubo

Infliximab versus intravenous immunoglobulin for refractory Kawasaki disease: a phase 3, randomized, open-label, active-controlled, parallel-group, multicenter trial

Masaaki Mori, Takuma Hara, Masako Kikuchi et al. · Scientific Reports · 2018 · 76 citations · Full text

Clinical characteristics and treatment of 50 cases of Blau syndrome in Japan confirmed by genetic analysis of the NOD2 mutation

Tomoko Matsuda, Naotomo Kambe, Yoko Ueki et al. · Annals of the Rheumatic Diseases · 2020 · 76 citations

Association of cord blood chemokines and other biomarkers with neonatal complications following intrauterine inflammation

Yoshikazu Otsubo, Kunio Hashimoto, Taro Kanbe et al. · PLoS ONE · 2017 · 35 citations · Full text

Assessment of type I interferon signatures in undifferentiated inflammatory diseases: A Japanese multicenter experience

Takayuki Miyamoto, Yoshitaka Honda, Kazushi Izawa et al. · Frontiers in Immunology · 2022 · 25 citations · Full text

A long-term follow-up of Japanese mother and her daughter with Blau syndrome: Effective treatment of anti-TNF inhibitors and useful diagnostic tool of joint ultrasound examination

Yoshikazu Otsubo, Ikuo Okafuji, Toshimasa Shimizu et al. · Modern Rheumatology · 2014 · 20 citations